text:
Parkinson's Disease
Aarsland D and Kurz MW. The epidemiology of dementia associated with Parkinson disease. J Neurol Sci. 2010 Feb 15;289(1-2):18-22. Epub 2009 Sep 4.
Abdin AA, Hamouda HE. Mechanism of the neuroprotective role of coenzyme Q10 with or without L-dopa in rotenone-induced parkinsonism. Neuropharmacology. Dec 2008;55(8):1340-1346.
Abreu RV et al. Chronic coffee and caffeine ingestion effects on the cognitive function and antioxidant system of rat brains. Pharmacol Biochem Behav. 2011 Oct;99(4):659-64. Epub 2011 Jun 15.
Allen NE et al. Balance and falls in Parkinson's disease: A meta-analysis of the effect of exercise and motor training. Mov Disord. 2011 Aug 1;26(9):1605-15. doi: 10.1002/mds.23790. Epub 2011 Jun 14.
Amadasi A, Bertoldi M, Contestabile R, et al. Pyridoxal 5'-phosphate enzymes as targets for therapeutic agents. Curr Med Chem. 2007;14(12):1291-1324.
Antonini A et al. A reassessment of risks and benefits of dopamine agonists in Parkinson's disease. Lancet Neurol. 2009 Oct;8(10):929-37. Epub 2009 Aug 24.
Astiz M et al. Effect of pesticides on cell survival in liver and brain rat tissues. Ecotoxicol Environ Saf. 2009 Oct;72(7):2025-32. Epub 2009 Jun 2.
Avramovich-Tirosh Y, Reznichenko L, Mit T, et al. Neurorescue activity, APP regulation and amyloid-beta peptide reduction by novel multi-functional brain permeable iron- chelating- antioxidants, M-30 and green tea polyphenol, EGCG. Curr Alzheimer Res. Sep 2007;4(4):403-411.
Balk E, Chung M, Raman G, et al. B vitamins and berries and age-related neurodegenerative disorders. Evid Rep Technol Assess (Full Rep). Apr 2006(134):1-161.
Barcia C et al. Inflammatory response in Parkinsonism. J Neural Transm Suppl. 2009;(73):245-52.
Beal MF. Bioenergetic approaches for neuroprotection in Parkinson's disease. Ann Neurol. 2003;53 Suppl 3:S39-47; discussion S47-38.
Bender A et al. Long-term creatine supplementation is safe in aged patients with Parkinson disease. Nutr Res. 2008 Mar;28(3):172-8.
Betarbet R et al. Chronic systemic pesticide exposure reproduces features of Parkinson's disease. Nat Neurosci. 2000 Dec;3(12):1301-6.
Bodis-Wollner I, Chung E, Ghilardi MF, et al. Acetyl-levo-carnitine protects against MPTP-induced parkinsonism in primates. J Neural Transm Park Dis Dement Sect. 1991;3(1):63-72.
Bondon-Guitton E et al. Drug-induced parkinsonism: A review of 17 years' experience in a regional pharmacovigilance center in France. Mov Disord. 2011 Jun 14. doi: 10.1002/mds.23828. [Epub ahead of print]
Bonifati V et al. mal recessive early onset parkinsonism is linked to three loci: PARK2, PARK6, and PARK7. Neurol Sci. 2002 Sep;23 Suppl 2:S59-60.
Bottiglieri T, Hyland K, Reynolds EH. The clinical potential of ademetionine (S-adenosylmethionine) in neurological disorders. Drugs. Aug 1994;48(2):137-152.
Bousquet M, Saint-Pierre M, Julien C, Salem N, Jr., Cicchetti F, Calon F. Beneficial effects of dietary omega-3 polyunsaturated fatty acid on toxin-induced neuronal degeneration in an animal model of Parkinson's disease. FASEB J. Apr 2008;22(4):1213-1225.
Braga CA et al. The anti-Parkinsonian drug selegiline delays the nucleation phase of α-synuclein aggregation leading to the formation of nontoxic species. J Mol Biol. 2011 Jan 7;405(1):254-73. Epub 2010 Nov 2.
Brooks AI et al. Paraquat elicited neurobehavioral syndrome caused by dopaminergic neuron loss. Brain Res. 1999 Mar 27;823(1-2):1-10.
Bureau G, Longpre F, Martinoli MG. Resveratrol and quercetin, two natural polyphenols, reduce apoptotic neuronal cell death induced by neuroinflammation. J Neurosci Res. Feb 1 2008;86(2):403-410.
Butt MS and Sultan MT. Coffee and its consumption: benefits and risks. Crit Rev Food Sci Nutr. 2011 Apr;51(4):363-73.
Calon F, Cole G. Neuroprotective action of omega-3 polyunsaturated fatty acids against neurodegenerative diseases: evidence from animal studies. Prostaglandins Leukot Essent Fatty Acids. Nov-Dec 2007;77(5-6):287-293.
Capitelli C, Sereniki A, Lima MM, Reksidler AB, Tufik S, Vital MA. Melatonin attenuates tyrosine hydroxylase loss and hypolocomotion in MPTP-lesioned rats. Eur J Pharmacol. Oct 10 2008;594(1-3):101-108.
Cassani E et al. Use of probiotics for the treatment of constipation in Parkinson's disease patients. Minerva Gastroenterol Dietol. 2011 Jun;57(2):117-21.
Cereda E et al. Low-protein and protein-redistribution diets for Parkinson's disease patients with motor fluctuations: a systematic review. Mov Disord. 2010 Oct 15;25(13):2021-34.
Chen D, Wang CY, Lambert JD, Ai N, Welsh WJ, Yang CS. Inhibition of human liver catechol-O-methyltransferase by tea catechins and their metabolites: structure-activity relationship and molecular-modeling studies. Biochem Pharmacol. May 15 2005;69(10):1523-1531.
Chen H et al. Nonsteroidal antiinflammatory drug use and the risk for Parkinson's disease. Ann Neurol. 2005 Dec;58(6):963-7.
Chen J, Tang XQ, Zhi JL, et al. Curcumin protects PC12 cells against 1-methyl-4-phenylpyridinium ion-induced apoptosis by bcl-2-mitochondria-ROS-iNOS pathway. Apoptosis. Jun 2006;11(6):943-953.
Cho HS, Kim S, Lee SY, Park JA, Kim SJ, Chun HS. Protective effect of the green tea component, L-theanine on environmental toxins-induced neuronal cell death. Neurotoxicology. Jul 2008;29(4):656-662.
Choi JY, Park CS, Kim DJ, et al. Prevention of nitric oxide-mediated 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson's disease in mice by tea phenolic epigallocatechin 3-gallate. Neurotoxicology. Sep 2002;23(3):367-374.
Chu CT. Diversity in the regulation of autophagy and mitophagy: lessons from Parkinson's disease. Parkinsons Dis. 2011;2011:789431. Epub 2011 Mar 17.
Clark J et al. Oral N-acetyl-cysteine attenuates loss of dopaminergic terminals in alpha-synuclein overexpressing mice. PLoS One. 2010 Aug 23;5(8):e12333.
Cleren C, Yang L, Lorenzo B, et al. Therapeutic effects of coenzyme Q10 (CoQ10) and reduced CoQ10 in the MPTP model of Parkinsonism. J Neurochem. Mar 2008;104(6):1613-1621.
ClinicalTrials.gov. Efficacy of Transdermal Nicotine, on Motor Symptoms in Advanced Parkinson's Disease (NICOPARK2). { http://clinicaltrials.gov/ct2/show/NCT00873392?term=nicotine+parkinson%27s&rank=1 }. Accessed 8/25/2011.
ClinicalTrials.gov. Study of the Neuro-protective Effect of Granulocyte-colony Stimulating Factor on Early Stage Parkinson's Disease. Available at http://clinicaltrials.gov/ct2/show/NCT01227681 Accessed 9/9/2011.
Corona T et al. A longitudinal study of the effects of an L-dopa drug holiday on the course of Parkinson's disease. Clin Neuropharmacol. 1995 Aug;18(4):325-32.
Corrigan FM et al. Organochlorine insecticides in substantia nigra in Parkinson's disease. J Toxicol Environ Health A. 2000 Feb 25;59(4):229-34.
De Araujo DP et al. The contributions of antioxidant activity of lipoic acid in reducing neurogenerative progression of Parkinson's disease: a review. Int J Neurosci. 2011 Feb;121(2):51-7. Epub 2010 Dec 2.
de Castro IP et al. Mitochondrial quality control and Parkinson's disease: a pathway unfolds. Mol Neurobiol. 2011 Apr;43(2):80-6. Epub 2010 Dec 1.
Devi L et al. Mitochondrial import and accumulation of alpha-synuclein impair complex I in human dopaminergic neuronal cultures and Parkinson disease brain. J Biol Chem. 2008 Apr 4;283(14):9089-100. Epub 2008 Feb 1.
Dhanasekaran M, Karuppagounder SS, Uthayathas S, et al. Effect of dopaminergic neurotoxin MPTP/MPP+ on coenzyme Q content. Life Sci. Jul 18 2008;83(3-4):92-95.
Dickman MS. von Economo encephalitis. Arch Neurol. 2001 Oct;58(10):1696-8.
Dimpfel W et al. Effects of rasagiline, its metabolite aminoindan and selegiline on glutamate receptor mediated signalling in the rat hippocampus slice in vitro. BMC Pharmacol. 2011 Feb 21;11:2.
Dobkin RD et al. Cognitive-Behavioral Therapy for Depression in Parkinson's Disease: A Randomized, Controlled Trial. Am J Psychiatry. 2011 Jun 15. [Epub ahead of print]
Dos Santos EF, Busanello EN, Miglioranza A, et al. Evidence that folic acid deficiency is a major determinant of hyperhomocysteinemia in Parkinson s disease. Metab Brain Dis. Mar 18 2009.
Dowling GA, Mastick J, Colling E, Carter JH, Singer CM, Aminoff MJ. Melatonin for sleep disturbances in Parkinson's disease. Sleep Med. Sep 2005;6(5):459-466.
Driver JA et al. Use of non-steroidal anti-inflammatory drugs and risk of Parkinson's disease: nested case-control study. BMJ. 2011 Jan 20;342:d198. doi: 10.1136/bmj.d198.
Evatt ML et al. Prevalence of vitamin d insufficiency in patients with Parkinson disease and Alzheimer disease. Arch Neurol. 2008 Oct;65(10):1348-52.
Exley R and Cragg SJ. Presynaptic nicotinic receptors: a dynamic and diverse cholinergic filter of striatal dopamine neurotransmission. Br J Pharmacol. 2008 Mar;153 Suppl 1:S283-97. Epub 2007 Nov 26.
Farah A et al. Chlorogenic acids from green coffee extract are highly bioavailable in humans. J Nutr. 2008 Dec;138(12):2309-15.
Fernandez-Espejo E. Pathogenesis of Parkinson's disease: prospects of neuroprotective and restorative therapies. Mol Neurobiol. Feb 2004;29(1):15-30.
Fleming L et al. Parkinson's disease and brain levels of organochlorine pesticides. Ann Neurol. 1994 Jul;36(1):100-3.
Flemming L et al. Parkinson's disease and brain levels of organochlorine pesticides. Ann Neurol. 1994 Jul;36(1):100-3.
Fong CY et al. Juvenile parkinsonism associated with heterozygous frameshift ATP13A2 gene mutation. Eur J Paediatr Neurol. 2011 May;15(3):271-5. Epub 2011 Feb 12.
Francis PT et al. The cholinergic hypothesis of Alzheimer's disease: a review of progress. J Neurol Neurosurg Psychiatry. 1999 Feb;66(2):137-47.
Francis PT. Biochemical and pathological correlates of cognitive and behavioural change in DLB/PDD. J Neurol. 2009 Aug;256 Suppl 3:280-5.
Freed CR et al. Transplantation of embryonic dopamine neurons for severe Parkinson's disease. N Engl J Med. 2001 Mar 8;344(10):710-9.
Gautam AH and Zeevalk GD. Characterization of reduced and oxidized dopamine and 3,4-dihydrophenylacetic acid, on brain mitochondrial electron transport chain activities. Biochim Biophys Acta. 2011 Jul;1807(7):819-28. Epub 2011 Apr 2.
Geisler S et al. PINK1/Parkin-mediated mitophagy is dependent on VDAC1 and p62/SQSTM1. Nat Cell Biol. 2010 Feb;12(2):119-31. Epub 2010 Jan 24.
Ghibu E et al. Antioxidant properties of an endogenous thiol: Alpha-lipoic acid, useful in the prevention of cardiovascular diseases. J Cardiovasc Pharmacol. 2009 Nov;54(5):391-8.
Ghosh A et al. Simvastatin inhibits the activation of p21ras and prevents the loss of dopaminergic neurons in a mouse model of Parkinson's disease. J Neurosci. 2009 Oct 28;29(43):13543-56.
Glass CK et al. Mechanisms underlying inflammation in neurodegeneration. Cell. 2010 Mar 19;140(6):918-34.
Guillot X et al. Vitamin D and inflammation. Joint Bone Spine. 2010 Dec;77(6):552-7. Epub 2010 Nov 9.
Guo S, Bezard E, Zhao B. Protective effect of green tea polyphenols on the SH-SY5Y cells against 6-OHDA induced apoptosis through ROS-NO pathway. Free Radic Biol Med. Sep 1 2005;39(5):682-695.
Guo S, Yan J, Yang T, Yang X, Bezard E, Zhao B. Protective effects of green tea polyphenols in the 6-OHDA rat model of Parkinson's disease through inhibition of ROS-NO pathway. Biol Psychiatry. Dec 15 2007;62(12):1353-1362.
Hampshire DJ et al. Kufor-Rakeb syndrome, pallido-pyramidal degeneration with supranuclear upgaze paresis and dementia, maps to 1p36. J Med Genet. 2001 Oct;38(10):680-2.
Hargreaves IP, Lane A, Sleiman PM. The coenzyme Q10 status of the brain regions of Parkinson's disease patients. Neurosci Lett. Dec 5 2008;447(1):17-19.
Hauser RA et al. Adenosine A2A receptor antagonists for Parkinson's disease: rationale, therapeutic potential and clinical experience. Drugs Aging. 2005;22(6):471-82.
Heisters D. Parkinson's: symptoms, treatments and research. Br J Nurs. 2011 May 13-26;20(9):548-54.
Henchcliffe C, Beal MF. Mitochondrial biology and oxidative stress in Parkinson disease pathogenesis. Nat Clin Pract Neurol. Nov 2008;4(11):600-609.
Hering R et al. Novel homozygous p.E64D mutation in DJ1 in early onset Parkinson disease (PARK7). Hum Mutat. 2004 Oct;24(4):321-9.
Herraiz T and Chaparro C. Human monoamine oxidase enzyme inhibition by coffee and beta-carbolines norharman and harman isolated from coffee. Life Sci. 2006 Jan 18;78(8):795-802. Epub 2005 Aug 31.
Holms AD et al. Acute nicotine enhances strategy-based semantic processing in Parkinson's disease. Int J Neuropsychopharmacol. 2011 Aug;14(7):877-85. Epub 2011 Feb 1.
Hong DP et al. Smoking and Parkinson's disease: does nicotine affect alpha-synuclein fibrillation? Biochim Biophys Acta. 2009 Feb;1794(2):282-90. Epub 2008 Oct 25.
Hu G et al. Coffee and tea consumption and the risk of Parkinson's disease. Mov Disord. 2007 Nov 15;22(15):2242-8.
Imamura K et al. The relationship between depression and regional cerebral blood flow in Parkinson's disease and the effect of selegiline treatment. Acta Neurol Scand. 2011 Jul;124(1):28-39. Epub 2010 Sep 29.
Inden M, Taira T, Kitamura Y, et al. PARK7 DJ-1 protects against degeneration of nigral dopaminergic neurons in Parkinson's disease rat model. Neurobiol Dis. 2006 Oct;24(1):144-58.
Iseki E et al. Degeneration process of Lewy bodies in the brains of patients with dementia with Lewy bodies using alpha-synuclein-immunohistochemistry. Neurosci Lett. 2000 May 26;286(1):69-73.
Jagatha B, Mythri RB, Vali S, Bharath MM. Curcumin treatment alleviates the effects of glutathione depletion in vitro and in vivo: therapeutic implications for Parkinson's disease explained via in silico studies. Free Radic Biol Med. Mar 1 2008;44(5):907-917.
Jak AJ. The Impact of Physical and Mental Activity on Cognitive Aging. Curr Top Behav Neurosci. 2011 Aug 5. [Epub ahead of print]
Jana S et al. Mitochondrial dysfunction mediated by quinone oxidation products of dopamine: Implications in dopamine cytotoxicity and pathogenesis of Parkinson's disease. Biochim Biophys Acta. 2011 Jun;1812(6):663-73. Epub 2011 Mar 4.
Jenner P et al. Molecular mechanisms of L-DOPA-induced dyskinesia. ture Reviews Neuroscience9, 665-677 (September 2008).
Jin F, Wu Q, Lu YF, Gong QH, Shi JS. Neuroprotective effect of resveratrol on 6-OHDA-induced Parkinson's disease in rats. Eur J Pharmacol. Dec 14 2008;600(1-3):78-82.
Kanda T et al. Combined use of the adenosine A(2A) antagonist KW-6002 with L-DOPA or with selective D1 or D2 dopamine agonists increases antiparkinsonian activity but not dyskinesia in MPTP-treated monkeys. Exp Neurol. 2000 Apr;162(2):321-7.
Kanthasamy AG et al. Dieldrin-induced neurotoxicity: relevance to Parkinson's disease pathogenesis. Neurotoxicology. 2005 Aug;26(4):701-19.
Kasture S et al. Assessment of symptomatic and neuroprotective efficacy of Mucuna pruriens seed extract in rodent model of Parkinson's disease. Neurotox Res. 2009 Feb;15(2):111-22. Epub 2009 Feb 20.
Katzenschlager R et al. Fourteen-year final report of the randomized PDRG-UK trial comparing three initial treatments in PD. Neurology. 2008 Aug 12;71(7):474-80. Epub 2008 Jun 25.
Katzenschlager R et al. Mucuna pruriens in Parkinson's disease: a double blind clinical and pharmacological study. J Neurol Neurosurg Psychiatry. 2004 Dec;75(12):1672-7.
Kempster PA et al. Relationships between age and late progression of Parkinson's disease: a clinico-pathological study. Brain. 2010 Jun;133(Pt 6):1755-62. Epub 2010 Apr 5.
Kenborg L et al. Parkinson's disease among gardeners exposed to pesticides - a Danish cohort study. Scand J Work Environ Health. 2011 Jun 17. pii: 3176. doi: 10.5271/sjweh.3176. [Epub ahead of print]
Khan FH et al. Inhibition of rat brain mitochondrial electron transport chain activity by dopamine oxidation products during extended in vitro incubation: implications for Parkinson's disease. Biochim Biophys Acta. 2005 Jun 30;1741(1-2):65-74. Epub 2005 Apr 14.
Khan NL et al. Clinical and subclinical dopaminergic dysfunction in PARK6-linked parkinsonism: an 18F-dopa PET study. Ann Neurol. 2002 Dec;52(6):849-53.
Khatibi NH et al. Granulocyte colony-stimulating factor treatment provides neuroprotection in surgically induced brain injured mice. Acta Neurochir Suppl. 2011;111:265-9.
Kim HJ. Stem cell potential in Parkinson's disease and molecular factors for the generation of dopamine neurons. Biochim Biophys Acta. 2011 Jan;1812(1):1-11. Epub 2010 Aug 14.
Kitagawa M et al. ffects of caffeine on the freezing of gait in Parkinson's disease. Mov Disord. 2007 Apr 15;22(5):710-2.
Klein AM, Ferrante RJ. The neuroprotective role of creatine. Subcell Biochem. 2007;46:205-243.
Klongpanichapak S, Phansuwan-Pujito P, Ebadi M, Govitrapong P. Melatonin inhibits amphetamine-induced increase in alpha-synuclein and decrease in phosphorylated tyrosine hydroxylase in SK-N-SH cells. Neurosci Lett. May 16 2008;436(3):309-313.
Kloppenborg RP et al. Homocysteine and cerebral small vessel disease in patients with symptomatic atherosclerotic disease. The SMART-MR study. Atherosclerosis. 2011 Jun;216(2):461-6. Epub 2011 Feb 24.
Knekt P et al. Serum vitamin D and the risk of Parkinson disease. Arch Neurol. 2010 Jul;67(7):808-11.
Koziorowski D and Friedman A et al. Levodopa "drug holiday" with amantadine infusions as a treatment of complications in Parkinson's disease. Mov Disord. 2007 May 15;22(7):1033-6.
Kraytsberg Y et al. Mitochondrial DNA deletions are abundant and cause functional impairment in aged human substantia nigra neurons. Nat Genet. 2006 May;38(5):518-20. Epub 2006 Apr 9.
Lau YS et al. Neuroprotective effects and mechanisms of exercise in a chronic mouse model of Parkinson's disease with moderate neurodegeneration. Eur J Neurosci. 2011 Apr;33(7):1264-74. doi: 10.1111/j.1460-9568.2011.07626.x. Epub 2011 Mar 7.
Lee MK, Kang SJ, Poncz M, Song KJ, Park KS. Resveratrol protects SH-SY5Y neuroblastoma cells from apoptosis induced by dopamine. Exp Mol Med. Jun 30 2007;39(3):376-384.
Lee MS et al. The effect of age on motor deficits and cerebral glucose metabolism of Parkinson's disease. Acta Neurol Scand. 2011 Sep;124(3):196-201. doi: 10.1111/j.1600-0404.2010.01446.x. Epub 2010 Sep 29.
Lesage S and Brice A. Parkinson's disease: from monogenic forms to genetic susceptibility factors. Hum Mol Genet. 2009 Apr 15;18(R1):R48-59.
Levites Y, Amit T, Youdim MB, Mandel S. Involvement of protein kinase C activation and cell survival/ cell cycle genes in green tea polyphenol (-)-epigallocatechin 3-gallate neuroprotective action. J Biol Chem. Aug 23 2002;277(34):30574-30580.
Levites Y, Weinreb O, Maor G, Youdim MB, Mandel S. Green tea polyphenol (-)-epigallocatechin-3-gallate prevents N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurodegeneration. J Neurochem. Sep 2001;78(5):1073-1082.
Levites Y, Youdim MB, Maor G, Mandel S. Attenuation of 6-hydroxydopamine (6-OHDA)-induced nuclear factor-kappaB (NF-kappaB) activation and cell death by tea extracts in neuronal cultures. Biochem Pharmacol. Jan 1 2002;63(1):21-29.
Lewis KA et al. Abnormal neurites containing C-terminally truncated alpha-synuclein are present in Alzheimer's disease without conventional Lewy body pathology. Am J Pathol. 2010 Dec;177(6):3037-50. Epub 2010 Nov 5.
Li R et al. (-)-Epigallocatechin gallate inhibits lipopolysaccharide-induced microglial activation and protects against inflammation-mediated dopaminergic neuronal injury. J Neurosci Res. 2004 Dec 1;78(5):723-31.
Li R, Peng N, Du F, Li XP, Le WD. Epigallocatechin gallate protects dopaminergic neurons against 1-methyl-4- phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity by inhibiting microglial cell activation. Nan Fang Yi Ke Da Xue Xue Bao. Apr 2006;26(4):376-380.
Li WW et al. Localization of alpha-synuclein to mitochondria within midbrain of mice. Neuroreport. 2007 Oct 8;18(15):1543-6.
Lieu CA et al. A water extract of Mucuna pruriens provides long-term amelioration of parkinsonism with reduced risk for dyskinesias. Parkinsonism Relat Disord. 2010 Aug;16(7):458-65. Epub 2010 May 31.
Lin CH, Huang JY, Ching CH, Chuang JI. Melatonin reduces the neuronal loss, downregulation of dopamine transporter, and upregulation of D2 receptor in rotenone-induced parkinsonian rats. J Pineal Res. Mar 2008;44(2):205-213.
Lin TK et al. Mitochondrial dysfunction and biogenesis in the pathogenesis of Parkinson's disease. Chang Gung Med J. 2009 Nov-Dec;32(6):589-99.
Liu G et al. alpha-Synuclein is differentially expressed in mitochondria from different rat brain regions and dose-dependently down-regulates complex I activity. Neurosci Lett. 2009 May 1;454(3):187-92. Epub 2009 Feb 28.
Ma J, Shaw VE, Mitrofanis J. Does melatonin help save dopaminergic cells in MPTP-treated mice? Parkinsonism Relat Disord. May 2009;15(4):307-314.
Mamo DC et al. Managing antipsychotic-induced parkinsonism. Drug Saf. 1999 Mar;20(3):269-75.
Mandel S, Maor G, Youdim MB. Iron and alpha-synuclein in the substantia nigra of MPTP-treated mice: effect of neuroprotective drugs R-apomorphine and green tea polyphenol (-)-epigallocatechin-3-gallate. J Mol Neurosci. 2004;24(3):401-416.
Mandel SA, Amit T, Kalfon L, Reznichenko L, Youdim MB. Targeting multiple neurodegenerative diseases etiologies with multimodal-acting green tea catechins. J Nutr. Aug 2008;138(8):1578S-1583S.
Mandel SA, Amit T, Weinreb O, Reznichenko L, Youdim MB. Simultaneous manipulation of multiple brain targets by green tea catechins: a potential neuroprotective strategy for Alzheimer and Parkinson diseases. CNS Neurosci Ther. Winter 2008;14(4):352-365.
Martignoni E, Tassorelli C, Nappi G, Zangaglia R, Pacchetti C, Blandini F. Homocysteine and Parkinson's disease: a dangerous liaison? J Neurol Sci. Jun 15 2007;257(1-2):31-37.
Martinez TN and Greenamyre JT. Toxin Models of Mitochondrial Dysfunction in Parkinson's Disease. Antioxid Redox Signal. 2011 Jul 12. [Epub ahead of print]
Mata IF et al. SNCA variant associated with Parkinson disease and plasma alpha-synuclein level. Arch Neurol. 2010 Nov;67(11):1350-6.
Matsuya T et al. Synergistic effects of adenosine A2A antagonist and L-DOPA on rotational behaviors in 6-hydroxydopamine-induced hemi-Parkinsonian mouse model. J Pharmacol Sci. 2007 Mar;103(3):329-32. Epub 2007 Mar 7.
McCollum M et al. Post-MPTP treatment with granulocyte colony-stimulating factor improves nigrostriatal function in the mouse model of Parkinson's disease. Mol Neurobiol. 2010 Jun;41(2-3):410-9. Epub 2010 Apr 21.
McGeer PL et al. Inflammation and neurodegeneration in Parkinson's disease. Parkinsonism Relat Disord. 2004 May;10 Suppl 1:S3-7.
McGeer PL et al. Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains. Neurology. 1988 Aug;38(8):1285-91.
McGeer PL, Zeldowicz L, McGeer EG. A clinical trial of folic acid in Parkinson's disease. Can Med Assoc J. Jan 22 1972;106(2):145-146 passim.
McKeith I. Commentary: DLB and PDD: the same or different? Is there a debate? Int Psychogeriatr. 2009 Apr;21(2):220-4. Epub 2009 Jan 28.
Medeiros CA, Carvalhedo de Bruin PF, Lopes LA, Magalhaes MC, de Lourdes Seabra M, de Bruin VM. Effect of exogenous melatonin on sleep and motor dysfunction in Parkinson's disease. A randomized, double blind, placebo-controlled study. J Neurol. Apr 2007;254(4):459-464.
Mizuno Y et al. Early addition of selegiline to L-Dopa treatment is beneficial for patients with Parkinson disease. Clin Neuropharmacol. 2010 Jan-Feb;33(1):1-4.
Montine KS, Quinn JF, Zhang J, et al. Isoprostanes and related products of lipid peroxidation in neurodegenerative diseases. Chem Phys Lipids. Mar 2004;128(1-2):117-124.
Moretto A and Colosio C. Biochemical and toxicological evidence of neurological effects of pesticides: the example of Parkinson's disease. Neurotoxicology. 2011 Aug;32(4):383-91. Epub 2011 Mar 23.
Mosharov EV. Interplay between cytosolic dopamine, calcium, and alpha-synuclein causes selective death of substantia nigra neurons. Neuron. 2009 Apr 30;62(2):218-29.
Muller T. Role of homocysteine in the treatment of Parkinson's disease. Expert Rev Neurother. Jun 2008;8(6):957-967.
Mythri RB, Jagatha B, Pradhan N, Andersen J, Bharath MM. Mitochondrial complex I inhibition in Parkinson's disease: how can curcumin protect mitochondria? Antioxid Redox Signal. Mar 2007;9(3):399-408.
Nie G, Cao Y, Zhao B. Protective effects of green tea polyphenols and their major component, (-)-epigallocatechin-3-gallate (EGCG), on 6-hydroxydopamine-induced apoptosis in PC12 cells. Redox Rep. 2002;7(3):171-177.
NINDS NET-PD Investigators. A pilot clinical trial of creatine and minocycline in early Parkinson disease: 18-month results. Clin Neuropharmacol. May-Jun 2008;31(3):141-150.
NINDS NET-PD Investigators. A randomized, double-blind, futility clinical trial of creatine and minocycline in early Parkinson disease. Neurology. Mar 14 2006;66(5):664-671.
Obeid R, McCaddon A, Herrmann W. The role of hyperhomocysteinemia and B-vitamin deficiency in neurological and psychiatric diseases. Clin Chem Lab Med. 2007;45(12):1590-1606.
Palhagen S et al. Selegiline slows the progression of the symptoms of Parkinson disease. Neurology. 2006 Apr 25;66(8):1200-6. Epub 2006 Mar 15.
Pallas M, Casadesus G, Smith MA, et al. Resveratrol and neurodegenerative diseases: activation of SIRT1 as the potential pathway towards neuroprotection. Curr Neurovasc Res. Feb 2009;6(1):70-81.
Pallas M, Verdaguer E, Tajes M, Gutierrez-Cuesta J, Camins A. Modulation of sirtuins: new targets for antiageing. Recent Pat CNS Drug Discov. Jan 2008;3(1):61-69.
Pan T, Jankovic J, Le W. Potential therapeutic properties of green tea polyphenols in Parkinson's disease. Drugs Aging. 2003;20(10):711-721.
Pandey N, Strider J, Nolan WC, Yan SX, Galvin JE. Curcumin inhibits aggregation of alpha-synuclein. Acta Neuropathol. Apr 2008;115(4):479-489.
Papapetropoulos S et al. Clinical heterogeneity of the LRRK2 G2019S mutation. Arch Neurol. 2006 Sep;63(9):1242-6.
Park JS et al. Pathogenic effects of novel mutations in the P-type ATPase ATP13A2 (PARK9) causing Kufor-Rakeb syndrome, a form of early-onset parkinsonism. Hum Mutat. 2011 Aug;32(8):956-64. doi: 10.1002/humu.21527. Epub 2011 Jul 12.
Parkinson J. An Essay on the Shaking Palsy. 1817. J Neuropsychiatry Clin Neurosci. 2002 Spring;14(2):223-36;discussion 222.
Parkinson's Disease Foundation. Statistics on Parkinson's. http://www.pdf.org/en/parkinson_statistics Accessed 8/1/2011.
Paus S, Schmitz-Hubsch T, Wullner U, Vogel A, Klockgether T, Abele M. Bright light therapy in Parkinson's disease: a pilot study. Mov Disord. Jul 30 2007;22(10):1495-1498.
Penumathsa SV, Maulik N. Resveratrol: a promising agent in promoting cardioprotection against coronary heart disease. Can J Physiol Pharmacol. Apr 2009;87(4):275-286.
Petrovitch H et al. Bowel movement frequency in late-life and substantia nigra neuron density at death. Mov Disord. 2009 Feb 15;24(3):371-6.
Pihlstrom L et al. Genetic variability in SNCA and Parkinson's disease. Neurogenetics. 2011 Jul 29. [Epub ahead of print]
Pimlott SL et al. Nicotinic acetylcholine receptor distribution in Alzheimer's disease, dementia with Lewy bodies, Parkinson's disease, and vascular dementia: in vitro binding study using 5-[(125)i]-a-85380. Neuropsychopharmacology. 2004 Jan;29(1):108-16.
Poorkaj P et al. parkin mutation analysis in clinic patients with early-onset Parkinson [corrected] disease. Am J Med Genet A. 2004 Aug 15;129A(1):44-50.
Postuma RB, Espay AJ, Zadikoff C, et al. Vitamins and entacapone in levodopa-induced hyperhomocysteinemia: a randomized controlled study. Neurology. Jun 27 2006;66(12):1941-1943.
Priyadarshi A et al. A meta-analysis of Parkinson's disease and exposure to pesticides. Neurotoxicology. 2000 Aug;21(4):435-40.
PubMed Health. Parkinson's disease; Paralysis agitans; Shaking palsy. (http://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0001762/). Accessed 8/17/2011.
Quik M et al. Nicotine and Parkinson's disease: implications for therapy. Mov Disord. 2008 Sep 15;23(12):1641-52.
Quist-Paulsen P. Statins and inflammation: an update. Curr Opin Cardiol. 2010 Jul;25(4):399-405.
Qureshi GA, Qureshi AA, Devrajani BR, Chippa MA, Syed SA. Is the deficiency of vitamin B12 related to oxidative stress and neurotoxicity in Parkinson's patients? CNS Neurol Disord Drug Targets. Feb 2008;7(1):20-27.
Rajagopalan P et al. Homocysteine effects on brain volumes mapped in 732 elderly individuals. Neuroreport. 2011 Jun 11;22(8):391-5.
Rajeswari A, Sabesan M. Inhibition of monoamine oxidase-B by the polyphenolic compound, curcumin and its metabolite tetrahydrocurcumin, in a model of Parkinson's disease induced by MPTP neurodegeneration in mice. Inflammopharmacology. Apr 2008;16(2):96-99.
Ramassamy C. Emerging role of polyphenolic compounds in the treatment of neurodegenerative diseases: a review of their intracellular targets. Eur J Pharmacol. Sep 1 2006;545(1):51-64.
Rascol O et al. A double-blind, delayed-start trial of rasagiline in Parkinson's disease (the ADAGIO study): prespecified and post-hoc analyses of the need for additional therapies, changes in UPDRS scores, and non-motor outcomes. Lancet Neurol. 2011 May;10(5):415-23. Epub 2011 Apr 7.
Rice JE et al. Disordered respiration as a levodopa-induced dyskinesia in Parkinson's disease. Mov Disord. 2002 May;17(3):524-7.
Roy A et al. Prospects of statins in Parkinson disease. Neuroscientist. 2011 Jun;17(3):244-55. Epub 2011 Jan 20.
Saaksjarvi K et al. Prospective study of coffee consumption and risk of Parkinson's disease. Eur J Clin Nutr. 2008 Jul;62(7):908-15. Epub 2007 May 16.
Samadi P, Gregoire L, Rouillard C, Bedard PJ, Di Paolo T, Levesque D. Docosahexaenoic acid reduces levodopa-induced dyskinesias in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine monkeys. Ann Neurol. Feb 2006;59(2):282-288.
Samii A et al. Parkinson's disease. Lancet. 2004 May 29;363(9423):1783-93.
Sanchez-Ramos J et al. Granulocyte colony stimulating factor decreases brain amyloid burden and reverses cognitive impairment in Alzheimer's mice. Neuroscience. 2009 Sep 29;163(1):55-72. Epub 2009 Jun 14.
Saravanan KS, Sindhu KM, Mohanakumar KP. Melatonin protects against rotenone-induced oxidative stress in a hemiparkinsonian rat model. J Pineal Res. Apr 2007;42(3):247-253.
Sardar AM et al. Dopamine deficits in the brain: the neurochemical basis of parkinsonian symptoms in AIDS. uroreport. 1996 Mar 22;7(4):910-2.
Saugstad LF. Are neurodegenerative disorder and psychotic manifestations avoidable brain dysfunctions with adequate dietary omega-3? Nutr Health. 2006;18(2):89-101.
Saugstad LF. Infantile autism: a chronic psychosis since infancy due to synaptic pruning of the supplementary motor area. Nutr Health. 2008;19(4):307-317.
Savica R et al. Medical records documentation of constipation preceding Parkinson disease: A case-control study. Neurology. 2009 Nov 24;73(21):1752-8.
Sawada H et al. Amantadine for dyskinesias in Parkinson's disease: a randomized controlled trial. PLoS One. 2010 Dec 31;5(12):e15298.
Schapira AH. Mitochondria in the aetiology and pathogenesis of Parkinson's disease. Lancet Neurol. 2008 Jan;7(1):97-109.
Schapira AH. Progress in neuroprotection in Parkinson's disease. Eur J Neurol. Apr 2008;15 Suppl 1:5-13.
Schouten HJ et al. Quality of Life of Elderly Patients With Antipsychotic-Induced Parkinsonism: A Cross-Sectional Study. J Am Med Dir Assoc. 2011 Feb 10.
Schwarz J, Trenkwalder C, Gasser T, Arnold G, Oertel WH. Folinic acid therapy fails to improve early Parkinson's disease: a two week placebo controlled clinical trial. J Neural Transm Park Dis Dement Sect. 1992;4(1):35-41.
ScienceDaily. Sciencedaily.com "Exact Brain Electrode Placement for Parkinson's Patients Now Possible; Research Opens the Way to More Precise Deep Brain Stimulation". Available at http://www.sciencedaily.com/releases/2011/09/110907075755.htm#.TmffQlmzs9w.email Accessed 9/8/2011.
Sethi P, Jyoti A, Hussain E, Sharma D. Curcumin attenuates aluminium-induced functional neurotoxicity in rats. Pharmacol Biochem Behav. Apr 16 2009.
Shimohama S. Nicotinic receptor-mediated neuroprotection in neurodegenerative disease models. Biol Pharm Bull. 2009 Mar;32(3):332-6.
Shults CW, Flint Beal M, Song D, Fontaine D. Pilot trial of high dosages of coenzyme Q10 in patients with Parkinson's disease. Exp Neurol. Aug 2004;188(2):491-494.
Shults CW, Oakes D, Kieburtz K, et al. Effects of coenzyme Q10 in early Parkinson disease: evidence of slowing of the functional decline. Arch Neurol. Oct 2002;59(10):1541-1550.
Singleton AB et al. alpha-Synuclein locus triplication causes Parkinson's disease. Science. 2003 Oct 31;302(5646):841.
Siniscalchi A, Mancuso F, Gallelli L, Ferreri Ibbadu G, Biagio Mercuri N, De Sarro G. Increase in plasma homocysteine levels induced by drug treatments in neurologic patients. Pharmacol Res. Nov 2005;52(5):367-375.
Song DD et al. Enhanced substantia nigra mitochondrial pathology in human alpha-synuclein transgenic mice after treatment with MPTP. Exp Neurol. 2004 Apr;186(2):158-72.
Song S et al. Granulocyte-colony stimulating factor (G-CSF) enhances recovery in mouse model of Parkinson's disease. Neurosci Lett. 2011 Jan 7;487(2):153-7. Epub 2010 Oct 14.
Steventon GB et al. A review of xenobiotic metabolism enzymes in Parkinson's disease and motor neuron disease. Drug Metabol Drug Interact. 2001;18(2):79-98.
Storch A et al. Randomized, double-blind, placebo-controlled trial on symptomatic effects of coenzyme Q(10) in Parkinson disease. Arch Neurol. 2007 Jul;64(7):938-44. Epub 2007 May 14.
Sun F et al. Dieldrin induces ubiquitin-proteasome dysfunction in alpha-synuclein overexpressing dopaminergic neuronal cells and enhances susceptibility to apoptotic cell death. J Pharmacol Exp Ther. 2005 Oct;315(1):69-79. Epub 2005 Jun 29.
Tan EK et al. Dose-dependent protective effect of coffee, tea, and smoking in Parkinson's disease: a study in ethnic Chinese. J Neurol Sci. 2003 Dec 15;216(1):163-7.
Tan EK, Cheah SY, Fook-Chong S, et al. Functional COMT variant predicts response to high dose pyridoxine in Parkinson's disease. Am J Med Genet B Neuropsychiatr Genet. Aug 5 2005;137B(1):1-4.
Tanaka K et al. Active and passive smoking and risk of Parkinson's disease. Acta Neurol Scand. 2010 Dec;122(6):377-82.
Thomas A et al. Duration of amantadine benefit on dyskinesia of severe Parkinson's disease. J Neurol Neurosurg Psychiatry. 2004 Jan;75(1):141-3.
Tohda C et al. Trigonelline-induced neurite outgrowth in human neuroblastoma SK-N-SH cells. Biol Pharm Bull. 1999 Jul;22(7):679-82.
Ueki A et al. Life style risks of Parkinson's disease: association between decreased water intake and constipation. J Neurol. 2004 Oct;251 Suppl 7:vII18-23.
Ugolino J et al. Mutant Atp13a2 proteins involved in parkinsonism are degraded by ER-associated degradation and sensitize cells to ER-stress induced cell death. Hum Mol Genet. 2011 Jun 23. [Epub ahead of print].
van Duijn CM et al. Park7, a novel locus for autosomal recessive early-onset parkinsonism, on chromosome 1p36. Am J Hum Genet. 2001 Sep;69(3):629-34. Epub 2001 Jul 2.
Van Humbeeck et al. Parkin interacts with ambra1 to induce mitophagy. J Neurosci. 2011 Jul 13;31(28):10249-61.
Vaughan CP et al. Behavioral therapy to treat urinary incontinence in Parkinson disease. Neurology. 2011 May 10;76(19):1631-4.
Virmani A, Gaetani F, Imam S, Binienda Z, Ali S. The protective role of L-carnitine against neurotoxicity evoked by drug of abuse, methamphetamine, could be related to mitochondrial dysfunction. Ann N Y Acad Sci. Jun 2002;965:225-232.
Virmani A, Gaetani F, Binienda Z. Effects of metabolic modifiers such as carnitines, coenzyme Q10, and PUFAs against different forms of neurotoxic insults: metabolic inhibitors, MPTP, and methamphetamine. Ann N Y Acad Sci. Aug 2005;1053:183-191.
Virmani A, Gaetani F, Imam S, Binienda Z, Ali S. The protective role of L-carnitine against neurotoxicity evoked by drug of abuse, methamphetamine, could be related to mitochondrial dysfunction. Ann N Y Acad Sci. Jun 2002;965:225-232.
Walker DG et al. Gene expression changes by amyloid beta peptide-stimulated human postmortem brain microglia identify activation of multiple inflammatory processes. J Leukoc Biol. 2006 Mar;79(3):596-610. Epub 2005 Dec 19.
Wang A et al. Parkinson's disease risk from ambient exposure to pesticides. Eur J Epidemiol. 2011 Jul;26(7):547-55. Epub 2011 Apr 20.
Wang C, Sadovova N, Ali HK, et al. L-carnitine protects neurons from 1-methyl-4-phenylpyridinium-induced neuronal apoptosis in rat forebrain culture. Neuroscience. Jan 5 2007;144(1):46-55.
Wang Q et al. Simvastatin reverses the downregulation of dopamine D1 and D2 receptor expression in the prefrontal cortex of 6-hydroxydopamine-induced Parkinsonian rats. Brain Res. 2005 May 31;1045(1-2):229-33. Epub 2005 Apr 22.
Whitworth AJ and Pallanck LJ. The PINK1/Parkin pathway: a mitochondrial quality control system? J Bioenerg Biomembr. 2009 Dec;41(6):499-503.
Williams A et al. Xenobiotic enzyme profiles and Parkinson's disease. Neurology. 1991 May;41(5 Suppl 2):29-32; discussion 32-3.
Willis GL, Turner EJ. Primary and secondary features of Parkinson's disease improve with strategic exposure to bright light: a case series study. Chronobiol Int. 2007;24(3):521-537.
Willis GL. Parkinson's disease as a neuroendocrine disorder of circadian function: dopamine-melatonin imbalance and the visual system in the genesis and progression of the degenerative process. Rev Neurosci. 2008;19(4-5):245-316.
Wolozin B et al. Simvastatin is associated with a reduced incidence of dementia and Parkinson's disease. BMC Med. 2007 Jul 19;5:20.
Wu Y, Tada M, Takahata K, Tomizawa K, Matsui H. Inhibitory effect of polyunsaturated fatty acids on apoptosis induced by etoposide, okadaic acid and AraC in Neuro2a cells. Acta Med Okayama. Jun 2007;61(3):147-152.
Wyss M, Schulze A. Health implications of creatine: can oral creatine supplementation protect against neurological and atherosclerotic disease? Neuroscience. 2002;112(2):243-260.
Xiao BG et al. Cell biology and clinical promise of G-CSF: immunomodulation and neuroprotection. J Cell Mol Med. 2007 Nov-Dec;11(6):1272-90.
Xie X et al. Adenosine and dopamine receptor interactions in striatum and caffeine-induced behavioral activation. Comp Med. 2007 Dec;57(6):538-45.
Xu X et al. The familial Parkinson's disease gene DJ-1 (PARK7) is expressed in red cells and plays a role in protection against oxidative damage. Blood Cells Mol Dis. 2010 Oct;45(3):227-32.
Yahr MD, Duvoisin RC, Cote L, Cohen G. Pyridoxine, DOPA, and Parkinsonism. Adv Biochem Psychopharmacol. 1972;4:185-194.
Yan J et al. Simvastatin prevents dopaminergic neurodegeneration in experimental parkinsonian models: the association with anti-inflammatory responses. PLoS One. 2011;6(6):e20945. Epub 2011 Jun 22.
Yang L et al. Combination therapy with coenzyme Q10 and creatine produces additive neuroprotective effects in models of Parkinson's and Huntington's diseases. J Neurochem. 2009 Jun;109(5):1427-39. Epub 2009 Mar 28.
Yang S, Zhang D, Yang Z, et al. Curcumin protects dopaminergic neuron against LPS induced neurotoxicity in primary rat neuron/glia culture. Neurochem Res. Oct 2008;33(10):2044-2053.
Youdim KA, Martin A, Joseph JA. Essential fatty acids and the brain: possible health implications. Int J Dev Neurosci. Jul-Aug 2000;18(4-5):383-399.
Yu W et al. The PINK1/Parkin pathway regulates mitochondrial dynamics and function in mammalian hippocampal and dopaminergic neurons. Hum Mol Genet. 2011 Aug 15;20(16):3227-40. Epub 2011 May 25.
Zbarsky V, Datla KP, Parkar S, Rai DK, Aruoma OI, Dexter DT. Neuroprotective properties of the natural phenolic antioxidants curcumin and naringenin but not quercetin and fisetin in a 6-OHDA model of Parkinson's disease. Free Radic Res. Oct 2005;39(10):1119-1125.
Zhang H, Jia H, Liu J, et al. Combined R-alpha-lipoic acid and acetyl-L-carnitine exerts efficient preventative effects in a cellular model of Parkinson's disease. J Cell Mol Med. 2010 Jan;14(1-2):215-25.
Zhang X et al. Mutation analysis of PINK1 gene in patients with early-onset Parkinsonism. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2011 Jun;36(6):490-7.
Zhao B. Natural antioxidants protect neurons in Alzheimer's disease and Parkinson's disease. Neurochem Res. Apr 2009;34(4):630-638.
Zhao YJ et al. Selegiline use is associated with a slower progression in early Parkinson's disease as evaluated by Hoehn and Yahr Stage transition times. Parkinsonism Relat Disord. 2011 Mar;17(3):194-7. Epub 2010 Dec 14.
Zhu J et al. Mitochondrial dysfunction in Parkinson's disease. J Alzheimers Dis. 2010;20 Suppl 2:S325-34.
Zoccolella S et al. Hyperhomocysteinemia in L-dopa treated patients with Parkinson's disease: potential implications in cognitive dysfunction and dementia? Curr Med Chem. 2010;17(28):3253-61.
Zoccolella S, Iliceto G, deMari M, Livrea P, Lamberti P. Management of L-Dopa related hyperhomocysteinemia: catechol-O-methyltransferase (COMT) inhibitors or B vitamins? Results from a review. Clin Chem Lab Med. 2007;45(12):1607-1613.


text:
Director: Rob Spallone
Company: VCA Pictures
Nicole Moore, Christian (I), Veronica Rayne, Robin Pachino, Jenner, Kitty Langdon, Brad Hardy, Mart Romano, Kelly Leigh
Critical Rating: AAA
Genre: Specialty
There's something downright old-fashioned about this title which collects five vignettes featuring older ladies.
You've got the "doctor do I need vaginal reconstruction surgery?" scene, the porn star audition scene, the delivery boy seduction, and even the old "hey that construction worker is actually a slutty girl!" scene. Generic sex action and mediocre lighting and editing don't inspire much either.
Kelly Leigh works hard deep throating and riding Marty Romano's cock in one of the better scenes, and hottie Veronica Rayne gets into some interesting positions with the always interesting Jenner.
This title comes packaged with a second DVD, Reel Sex Vol. 1: Older Women, Better Sex, a reissue of a title from a few years ago, which is better pretty much all around, though it is an all-condom movie.
Retailing: The bonus disc makes this a good value proposition for MILF lovers.

subset: commoncrawl


text:
Chairman Conaway: TPA is Important for Agriculture
Today, House Agriculture Committee Chairman K. Michael Conaway (R-TX) issued the following statement on the introduction of Trade Promotion Authority (TPA) legislation.
Tamara Hinton, 202.225.0184
WASHINGTON – This week during The Ag Minute, guest host Rep. Steve King discusses H.R. 3010, the Regulatory Accountability Act, which the U.S. House of Representatives is slated to consider this week. The bill ensures that regulators do not impose unjustified costs on job creators during a time when the U.S. economy can least afford it. This bipartisan bill is part of House Republicans' ongoing effort to put in place policies that will encourage job creation.
Click here to listen to The Ag Minute. The transcript is below.
"Job creation is the key to economic recovery and small businesses are our nation's main job creators. But a recent gallop poll indicates that one in three small business owners across the country are worried about going out of business.
"Why? Because of the time and cost required to comply with government regulations.
"This is a complaint I hear about a lot from my rural constituents back home in Iowa. And, this is why I am an original co-sponsor of H.R. 3010, the Regulatory Accountability Act. This bipartisan bill requires that agencies do a better job of determining what regulations are needed before implementing new rules. It also requires agencies to assess both the costs and benefits of regulations and possible alternatives.
"In the midst of a fragile economy, we should be looking for ways to improve economic opportunities for jobs creators, not saddling them with more regulations.
"H.R. 3010 ensures that regulators do their due diligence. It protects farmers, ranchers, and small businesses from an overzealous regulatory regime."
The Ag Minute is Chairman Lucas's weekly radio address that is released from the House Agriculture Committee.


text:
The "kiss" again describes the concept of the Two becoming One integrated "witness" to the Heart of God. Elisha laid on the "son"...mouth to mouth.
34 is the Kiss...pey 17 on pey17.
That's an awesome connection to Rachael, Bob! (and the blood crying out from the ground). Rachael is the Mother heart of God...where the plummet line is laid (and raised) in the New Jerusalem/Mother/Bride. It is "Rachael" (pulling on that "scarlet thread/line") ,who draws Heaven(spirit) into Earth(matter) for the consummation. (to raise her children out of captivity)
The "scarlet thread" or "blood" becomes the LIPS around the mouth(pey..17) of the Beloved, in the S.O.S. The books open with her cry: LET HIM KISS ME WITH THE KISSES OF HIS MOUTH
Last edited by kathryn; 12-20-2011 at 06:25 AM.
The "kiss" again describes the concept of the Two becoming One integrated "witness" to the Heart of God. Elisha laid on the "son"...mouth to mouth.
34 is the Kiss...pey 17 on pey17.
רחל H7354 Rachel / Rachel 238 Resh 200, Chet 8, and Lamed 30
Factors: 238 = 2 x 7 x 17
Jacob had to work 2x7 years to get the promised Rachel as his wife.
She gave birht to Joseph who was 17 when he recieved the inheritance. Coat of many colors.
This is the triangle we are talking about here. The Neshamah or higher aspect of soul as opposed to the lower triangle of Nepesch or animal soul of the world of Formation.
Here are some aspects that I can see. The woman in the strength card is in control of the lion. This is Satan
1pe 5:8 Be sober, be vigilant; because your adversary the devil, as a roaring lion, walketh about, seeking whom he may devour:
In the Qabala the serpent only reaches to Tipareth or Daath.
The woman in the card has the figure 8 horizontal above her head and also around her waist.
It is the second crossover or horizontal path on the tree.
The letter Teth is assigned to this card. The snake eating it's own tail.
This may have something to do with the moon turning to blood.
Ge 31:34 Now Rachel had taken the images, and put them in the camel's furniture, and sat upon them. And Laban searched all the tent, but found them not.
Ge 31:35 And she said to her father, Let it not displease my lord that I cannot rise up before thee; for the custom of women is upon me. And he searched, but found not the images.
The images of Yesod reinterpreted to conform to the blood of Christ possibly. The blood covenant.
We also have the Hermit card which is like Joseph. "Blessed is he who was separate from his bretheren."
The letter is the single flame of Yod. Or hand of God. The Hermit is a forerunner, like Joseph,..Standing on a mountain holding his staff and a lantern to light the way for those who would come after.
There is also Justice who is blindfolded to show impartiality. In other words, the whole picture rather than parts only. She also implies Balance which is what the tree of life is all about and is summed up in Tipareth the center of the tree.
Also Jesus said that justice or judgement and mercy were the weightier matters of law and that looking at appearances, we miss those weightier matters. Joseph was a Just man and was of a mind to put Mary away privily instead of having her stoned. Her letter is Lamed and it is the 22nd path on the tree.
Harry Potter,.. "Is this all happening in my head, or is it real?"
Professor Dumbledor,.. "Of course it's all happening in your head. What makes you think that means it isn't real?"
This may have something to do with the moon turning to blood.
Yes it does. It's that two-sided coin again expressing two concepts that are one "event". The circumsized heart is fully engorged with blood (upright...erection) in the consummation of the Sun/Son and "sister/Bride" moon. Of course, this is the end of the "tail" of the serpent. When it is decapitated, what was the tail becomes the HEAD. (death is SWALLOWED up in VICTORY...17...THE PEY OR MOUTH.) It is also the CUP full of NEW WINE.
It is the fall of Jericho (moon..carnal mind) and the FULL renewing of the Mind of Christ in the Bride.
Last edited by kathryn; 12-20-2011 at 08:53 AM.
OK! I will definitely set aside some time to watch that movie. I love the "Impossible Dream" song ~ I'm not sure I knew it was from that movie.
And yes, Yesod is a "whore" indeed when lit only by the lower light. And I suspect I agree with your teacher that no one "wins" the battle with mirrors since all illusions must be shattered before freedom can be found. And your self-conception is definitely full of illusions, prejudices, biases, etc.
It is fascinating how Christians have lost the greatest vision of Christianity, which is our place as gods in the cosmic scheme of things. Thanks for reminding me.
Yes, there is a peace and a clarity of vision that comes recognizing our place relative to the rest of the Living Cosmos.
The realization that we are truly eternal relative to all that is really helps put my heart and mind at peace. We have "all the time in the world" to work things out. So we should slow down and learn to play music.
We are infinitely more than clay vessels! It's all a question of where your consciousness resides, or with what you identify.
Yes indeed ... I do know what you are saying! And oddly enough, I can't find a threat to my "sanity" since "sanity" is like knowing how to walk, and you are talking about dancing. In other words, they are not mutually exclusive at all. The apparent threat to "sanity" is only how it looks to those who are uninitiated. Like the fear that grips a shy kid before he steps and and enters into the world of the living. Or like Dumbo before his first flight before he had sufficient self-confidence to fly without his magic feather. Perfect dream that was for me!
I can't thank you enough for being here to talk through these things with me. It's very helpful. Opening doors to perceive a whole universe in which my little "house" (mind) is embedded.
It is interesting that you and I and RC Christian have all done that. I hope he comes back soon. He catalyzed this transformation in a big way because of synchronicities in our posts to each other that led me to write up my Dumbo Dream.
That Rabbis call the "world of interpretation" PRDS whence we get the word "PaRaDiSe" which relates directly to "Eden." And what do we know of "Eden" or any of these things except through interpretations of words in the Bible? Thus, the Bible is speaking of itself as both the "Tree of Life" and the "Tree of Knowledge of Good and Evil." This understanding transforms everything.
I love the alchemy you suggest - Luke 11:11 If a son shall ask bread of any of you that is a father, will he give him a stone? The book contains it's own keys!
I feel like I've always known this. How did I forget?
Now the words are weaving themselves. The sudden sense of "how did I forget this" arose just before I came to this comment. I feel like I'm waking up in a most literal sense.
That makes sense.
It could still be a "moral" teaching expressed in hyperbole (no one is supposed to really pluck out their eye).
And I think that is true for those who need that kind of teaching. But it has a much deeper aspect that reminds the adept the path to spiritual maturity. It is not that there is some great "sin" in adultery that will be punished by a "law" but rather that it would be like poking yourself in your eye. It deceives. It does not satisfy and it is not good. The idea that the problem is that it's a "violation of God's law" is for people who are very immature and need to be told what to do. The mature soul are "those who by reason of use have their senses exercised to discern both good and evil." They are not under any kind of external law. We are absolutely free. That is the essence of our being.
Yes indeed, it was easy!
Last night I had an insight to the idea of blood bearing witness. Dalet (Door) of Mem(ory) - the elephant never forgets! This is the Key. The purpose of our metaphysical categorical systems is to assist the mind to remember the aspects of Reality that are not visible and that are easily obscured or forgotten.
This is all about memory - remembering - awakening to our true identity as Divine Beings.
It's been an long night of very curious dreams. We are now awakening.
- Skepticism is the antiseptic of the mind.
- Remember why we debate. We have nothing to lose but the errors we hold. Who but a stubborn fool would hold to errors once they have been exposed?
Check out my blog site
Very cool Richard,
We are Petros, little stones that have been broken off from the big stone Petra.
and meory is a big part of it. Some things that have happened to me, even though I had never experienced them before always have a familiar feeling none-the-less.
Lets try to stay in it.
It's a blast.
Last edited by Bob May; 12-20-2011 at 10:53 AM.
Harry Potter,.. "Is this all happening in my head, or is it real?"
Professor Dumbledor,.. "Of course it's all happening in your head. What makes you think that means it isn't real?"
Interrupting regular programming to say Happy Birthday to Bob!
May your New Year gush forth in Living Water!
That's Grace for you, Bro! http://www.biblewheel.com/gr/gr_58.asp
You said: "Now, the further apart the eyes the more apparent the illusion of interpretation is.
So, either we are reinterpreting two lies, or making one lie out of two separate truths. Which is it?"
This makes me think of religious experience which many of us have encountered.
We are convinced that we have encountered someone who is real and alive. And not just a concept.
But people will ask: "How do you know that you have experienced the divine presence and that you are
not fooling yourself?" In most cases, there is no way to prove that we experienced what we did, which is
true for any experience. But then again, how can I prove that I am not dreaming now. As I type my thoughts to you, how can I prove that behind this computer screen you are sitting there and that under your skin there is feeling and imagining? When I communicate with you like this, am I not communicating with more than your body? The fact is
that I have never seen your mind, and I have entered into a relationship with you. I trust my intuition that I am communicating with a human being, and not just a human body. So why should I not trust my intuition that I am in the presence of a divine person?
There are currently 1 users browsing this thread. (0 members and 1 guests)


text:
California based iZZi Gadgets makes technology chic with their accessories for Apple. Proudly introducing the iZZi Orbit for the iPhone 4/4S and iPhone 5, their latest gadget uses Peripheral Motion Lock Technology in conjunction with three interchangeable lens options — telephoto, fisheye, and wide angle — allowing you to see your world as through your […]
Experience the world through telephoto, fisheye & wide angles
The latest video from "Angles" LP
The Strokes return with "Taken For A Fool", the latest alternate reality video from their Angles LP. The Strokes also played a version of the track with Elvis Costello when the band played Madison Square Garden in April, and that version will be included as a B-Side for the official single. "Taken For A Fool" […]


text:
[SLAC] [SLAC Pubs and Reports]
Novel QCD Effects in The Production and Decay of QuarkoniumAbstract
Full Text
- slac-pub-7306 (191 KB)
Compressed PostScript
- slac-pub-7306 (48.1 KB)
Alternate download methods: old, ancient*
*download methods - technical infotechexplorer
- slac-pub-7306 (12.8 KB)
More Information
Full bibliographic data for this document, including its complete author list, is (or soon will be) available from SLAC's SPIRES-HEP Database.
Please report problems with this file to email@example.com. The SLAC preprint inventory is provided by the SLAC Technical Publications Department.
Page generated 02 May 2001 @ 11:44 PDT by htmlme.pl


text:
The Saraswat Co-op Bank Ltd, F C Road Details:
Note:If you think there are any discrepancies in this information please let us know(firstname.lastname@example.com)
we will verify the information and make necessary changes. Please include all the details of the bank when contacting us. Bank Name: The Saraswat Co-op Bank Ltd Branch Name: F C Road Address: Ganesh Wadi, F.C. Road, Shivaji Nagar, Pune - 411 004. City: F C Road District: PUNE State: Maharashtra Phone: 022-28347702/28352508/28364233 Email: firstname.lastname@example.com Micr Code: 411088004 IFSC Code: SRCB0000035 Website: |


text:
Results 1 to 4 of 4
- 01-27-2013, 08:09 AM Thread Author #1
Charging Problem
My phone doesn't want to charge even though the LED light is red , it says in the power settings that the phone is charged with the USB but there is no actual charging and the percentage of charging doesn't want to increase at all , and with time the charge decreases as if there is no charging done at all... I tried removing the charge and putting it again but still same problem I even reset my phone but nothing changed with this problem...is there something I can do to fix it?? Thanks in advance.
Re: Charging Problem
Hello, it's strange that I am having the exact same problem as you. I guess doing a search before asking helps...I will post a description of my problem in conjunction with this thread as it appears we may be experiencing the same difficulties.
Over the last week or so, I've had days where the phone would charge fine, and other days where the phone would not charge at all, or would quickly lose battery life. This morning was the worst so far. From a full charge the phone lost 100% battery life in just over an hour. I tried a hard reset as a last ditch effort. The phone is now dead and although it is plugged in with the red charging light, it will not even turn on. If it does manage to get to the home screen it immediately states that it will shut off due to the battery being dead.
I am not sure what to do as the battery works fine some days, and doesn't function at all on others. Is this a normal process for a dying battery? I would assume that it would just slowly deteriorate without any gain in functionality. I can't imagine a rogue app being the reason for the problem as it still exists after a hard reset.
Am I going to have to get a new battery? Should I bring it in to a phone repair shop? Does anybody know what the hell is going on!?
Thanks! - 03-02-2013, 05:57 PM #3
Re: Charging Problem
i have the same problem with my incredible s. it never charged at all when i plugged it to the wall charger, and my usb cord is kinda loose too. ive charged it like more than 12 hours. and when i changed my battery with my mum, same problem happend and she can charged my battery with her phone but i cant charged both when using my phone. seems that the battery is ok. i even used different cables like samsung but the cord seems to loose with all cables do u think the cord may caused the battery to not fully charged? and have u solved ur problem? if u did let me know. im going to take my htc to a repair shop tomorrow, ive been using my phone about 2 years + and the warranty was a year ago. sorry for my writing, im not really fluent in english. hope to hear a reply from u asap. thanks
Similar Threads
Evo charging problems
By logicalform in forum HTC EVO 4GReplies: 12Last Post: 09-23-2010, 12:19 AM -
Bump charging problem...
By nneptune in forum Verizon Droid IncredibleReplies: 5Last Post: 06-25-2010, 10:28 AM -
Charging Problems (OEM Charger)
By illwood in forum HTC EVO 4GReplies: 9Last Post: 06-22-2010, 03:40 PM -
battery charging problem
By bnesws757 in forum Motorola DroidReplies: 4Last Post: 06-17-2010, 10:21 AM -
odd charging problem....
By clafountaine in forum HTC EVO 4GReplies: 1Last Post: 06-09-2010, 02:45 AM


text:
FiltersShow / Hide
- Anywhere In The UK
- Location: Anywhere in the UK
Radius: ... miles
Renowned hard touring band with songs that make you want to dance, laugh, cry or even just jump for joy. It could be classed as folk music, it could be indie rock or maybe it's just good music.
See more info at oysterband.co.uk
Image © Judith Burrows
5 Oysterband Tour Dates
Track Oysterband
- You are tracking Oysterband
- Receive email as soon as new tour dates are announced
- 1,129,168 fans now rely on Ents24 alerts
- Alerts are free and always will be!
- We never share details with 3rd parties
July 2015
August 2015
Ents24 Widget
Customisable, flexible tour date widget… Super quick set-up, get the code here: tour dates on your web siteNews and Announcements RSS feed
- Tuesday 5th May: Oysterband announced a new Cottingham date
- Wednesday 29th Apr: Shrewsbury Folk Festival 2015 added Oysterband to the roster
Have Your Say
- Read the full review and 2 more
I have seen the Oysterband several times and in a variety of venues. The first time was at Womad in St Austell and most recently at the Green Man Festival in Clun, Shropshire. They are brilliant live - so much better than on CD although their CDs are pretty good… (cont'd) Annie from Onibury
Have you seen Oysterband? Write a review
Fans who like 'Oysterband' also like:
Do you represent Oysterband, or are you a member of their promotional team? Click here to claim this page


text:
I was woken up this morning by the sound of a package falling onto the doormat. That noise is enough for me to scurry quickly out of bed, far quicker than I ever would if it was a workday! Delivered this morning was my prize from the asking for trouble blog giveaway. Kawaii notebooks, badges, gingerbread men & an uber cute bread slice charm. Thank you!
Back to my crafting, my opt art blanket is finished and in the post, will share photos soon. In the meantime I have cast on some Wise Hilda socks for me, using some beautiful variegated drops yarn that I won from a playful day podcast giveaway.
The pattern is suitably simple, so that I can knit away whilst daydreaming or watching tv. And, I'd forgotten just how much I like using a variegated yarn, I find myself calling out the colours as I knit along "oooh, purple", "oooh, green!" :)
Monday, 23 January 2012
Gingerbread men in the post...
A Playful Day,
angelina fibres,
asking for trouble,
3 comments:
Subscribe to:
Post Comments (Atom)


text:
Mikel Leshoure #25 RB
Detroit Lions | Official Team Site
Height: 6-0 Weight: 233 Age: 25
Born: 3/30/1990 Streator , IL
College: Illinois
Experience: 4th season
High School: Centennial HS [Champaign, IL]
Draft 2011
Pick No.57
Selected By: Detroit Lions
Round: 2
Pick (Overall): 25 (57)
Pick Analysis:
With some improvements on third down, Leshoure has the size, athleticism and competitiveness to develop into an every-down back. Displays very good burst and quickness for a big back, can get the corner and make defenders miss, but does not have elite speed. Possesses the power to break tackles, push the pile and find the end zone near the goal line, but needs to do a better job of staying low. Has the size and mentality to become an effective pass blocker and the athleticism to turn into a weapon in the passing game but is currently raw in both areas. Leshoure is a second-round prospect.


text:
Cancer Control Research
5R03CA121006-02Weitlauf, Julie C.
DESCRIPTION (provided by applicant): This study will examine an issue not yet addressed in the extant literature whether posttraumatic stress disorder (PTSD) is a risk factor for decreased cervical cancer surveillance care among women. Further analyses will assess the additional contributions of comorbid psychiatric and substance use disorders while controlling for the potential confounding effects of demographic factors including age, race/ethnicity, and other medical comorbidities to the likelihood of receiving guideline-concordant screening. To achieve these objectives, we will capitalize on existing data sources that include VA's National Patient Care Database, a rich national database that includes health care utilization data on all women receiving care in VA. This work will lay the foundation for subsequent studies that will include primary data collection to better understand the relationships between PTSD and receipt of guideline-concordant cervical cancer surveillance (CCS). Our long-term goals include the implementation of intervention studies, based upon the findings of this study that will target specific cohorts of women with PTSD for improved adherence to CCS guidelines. PTSD may be an important source of variability in CCS, as a result of patient-level or provider-level factors. Behavioral factors such as avoidance are common in PTSD and may increase the likelihood that some women will postpone or avoid preventive GYN care. Such avoidance may be particularly pronounced among women whose PTSD was caused by the leading precipitant in women, i.e., sexual trauma, as invasive exams may trigger traumatic memories of a prior assault. Moreover, the interpersonal features of PTSD (i.e., poor communication skills, anger, and hostility) and commonly comorbid psychiatric symptoms (i.e., anxiety) may interfere with doctor-patient interactions and adversely impact women's quality of care. Prior work has determined that patients perceived as "difficult" tend to receive lower quality care from busy clinicians. Therefore, it is highly likely that women with PTSD receive less consistent CCS. However, to our knowledge this issue has not yet been examined.


text:
Nicole's Gourmet Foods
921 Meridian Ave.
South Pasadena, CA 91030
South Pasadena, CA 91030
- Sun 10am-5pm, Mon-Wed 9am-6pm, Thu 9am-8pm, Fri-Sat 9am-5:30pm
- $
- Catering, Patio/Sidewalk Dining, Takeout
- Breakfast, Lunch
- Beer/Wine
- Street Parking
- Reservations Not Accepted
Nicole Grandjean wants people to know about French food. To this end, she offers her gourmet imports to the public at the same prices she sells them to restaurants. Her pretty, spacious shop in South Pasadena also contains a sandwich counter and a small number of tables on the patio - a perfect secret lunch spot. But dangerous. You might stop in for a croque monsieur (ham, Gruyere and bechamel melted together on a baguette) and walk out having bought a Laguiole knife set, a Provencal tablecloth, some frozen porcinis and a big chunk of fresh foie gras. A meal-sized salad (the authentic Greek, or the one with smoked duck breast and dried cherries) could cost you the price of any number of European and domestic cheeses, kilos of chocolate, and a gallon of olive oil. The good news is, you won't spend a fraction of what you would elsewhere. Nicole's is a great resource to those of us Francophile gastronomes who don't have the wherewithal to keep a pied a terre in Paris; and with Grandjean's public-friendly prices, she's taken great foodstuffs out of the realm of sheer luxury and turned them into affordable, simple pleasures.
View All
More French Restaurants in Pasadena and vicinity
View All
More French Restaurants in Los Angeles
Travel back in time to the elegance of French colonial Vietnam at Crustacean, where executive che...
Asian -
The Taix family has been running this French restaurant since 1927, and in this location as a vir...
French -
Babette's Feast is a boulangerie/patisserie par excellence, laying out a spread of delectable, mo...
Bakery -
A screenwriter and actor rendez-vous spot, Figaro channels old Hollywood in Los Feliz, with its F...
French -
The California-Mediterranean cooking of Suzanne Goin, which is feminine in all the best ways, is ...
California -
It's a modest neighborhood mom-and-pop or should we say mere-et-pere cafe nestled among several i...


text:
Johnson continues momentum by snagging pole
Ranked just 27th in Friday afternoon's practice session, Johnson gave his competitors a false sense of security. Then, he put down a of 191.076 mph around the 1.5-mile oval to earn the No. 1 starting spot for the AAA Texas 500. Keselowski, his nearest competitor, will chase him from the eighth starting spot. On Friday he watched Johnson win his second consecutive pole and third in the eight Chase for the Sprint Cup races.
"I stayed on the throttle and kept the car pointed in the right direction." Johnson, who has a two-point lead on Brad Keselowski with three races left in the season, will get his choice of pit stall and have everyone chasing him Sunday afternoon. Green flag is scheduled for 3:16 p.m. ET. POST QUALIFYING PRESS CONFERENCE TRANSCRIPT JIMMIE JOHNSON, NO. 48 LOWE'S CHEVROLET – P0LE WINNER: MOST GUYS WHO MAKE QUALIFYING RUN MOSTLY BACKUP WHAT THEY DID IN PRACTICE, YOU PICKED UP 3/4 OF A SECOND, WAS THAT MOSTLY DUE TO HOW WELL YOU UNLOADED OR IMPROVEMENT IN THE CAR? DID YOU THINK YOU HAD A TOP-10 CAR, OR DID YOU THINK YOU HAD A SHOT AT THE POLE? DOES WINNING THE POLE HERE MEAN ANY MORE THAN WINNING THE POLE LAST WEEK OR WINNING THE POLE AT CHICAGO? "I really felt like top-10 was the goal. When I heard the lap time, I was way impressed. I think the pole here in the spring was a .30 and it was probably cooler, and to be down in the .20s, I was really pleased with that. We exceeded expectations in qualifying. A top-10 was really the goal going into it, especially with our seeding process, we felt like going out as early as we did, the guys later would have a bigger advantage, and pick up some speed on us. We definitely exceeded expectations. As you get closer to the end of the year, they feel like they mean a little bit more. But, it's just another pole. Not saying that in a negative way, but the benefits that come with it are the same that you would have at any other track. We have 500 long, grueling miles on Sunday, so we won a battle today. But the larger battle is definitely on Sunday here at the track. Hopefully all of these battles that we are winning right now will total up to winning the war at the end of the year." CAN YOU CONFIRM IF YOU ARE SUPERSTITIOUS? "No, not at all man. What would make you think that? (LAUGHS)." WHEN YOU TURNED THAT LAP, DID YOU THINK YOU WOULD BE SITTING IN YOUR CAR FOR 35-40 MINUTES, AND HOW WAS IT? "I was ready to get out, and my engine tuner stuck his head in the car and said 'Hey man, you are going to be sitting here a long time this week'. And I went 'Oh yea, that is right. I'm not superstitious, but I'll sit here'. And, I sat there. It doesn't mean anything, but may as well. At this point in the season, you have to pull out the stops. It gives us a nice talking point I guess through it all. (LAUGHS). IF YOU WERE CHASING A GUY FOR A CHAMPIONSHIP AND THAT GUY THREW UP A LAP LIKE YOU DID TODAY, WHAT WOULD YOU THINK? "It's funny, because when you run really well, you build confidence in your own head, and around your team about how things went. And we'll certainly do that in the No. 48 (team) if we qualified 10th, we would have went 'Hey, that met expectations of what we thought we'd get. Good job'. 25th would be 'Hey, it's just qualifying'. So, long story short, every team will put a spin on it to help themselves, and to help get over it. I mean, I don't think the No. 2 (Brad Keselowski) qualified all that bad. I think he's in the top-10. Truthfully, if you're in the top-10 each week, you eliminate so many more issues on the race track. You have a good pit stall pick, decent air, and that's really the goal we are all shooting for. Getting poles are pretty special, and we got a good one today, and in a timely point in the season. Us racers will find a way to put the spin on it we need for any given situation." YOU SAID LAST WEEK AFTER MARTINSVILLE TALKING ABOUT WHAT HAPPENED TO DENNY HAMLIN THAT KIND OF STUFF CAN BEFALL EVERY TEAM. YET THEY NEVER SEEM TO BEFALL YOU OR REALLY HENDRICK (MOTORSPORTS) VERY MUCH EITHER. I KNOW YOU HAVE NEVER DRIVEN FOR ANOTHER TEAM, BUT DO YOU HAVE A SENSE OF WHY YOU GUYS CAN AVOID THE QUALITY CONTROL STUFF THAT SEEMS TO AFFLICT OTHER POWERHOUSES IN NASCAR? FOLLOWING UP ON THAT I CAN RECALL BLOWN ENGINES THROUGHOUT THE YEAR, BUT IN THE CHASE YOU DON'T SEEM TO HAVE THESE MECHANICAL ISSUES. CAN YOU RECALL A MECHANICAL ISSUE IN YOUR CHASES WHEN YOU HAVE BEEN THE CHAMPION? "In 2006 we had a spark plug fail at Loudon. We were running around on seven cylinders, maybe it wasn't the plug; it was the boot or the plug, something with it I was on seven cylinders. Then tangled up with Sterling Marlin and crashed in turns one and two and have that DNF (did not finish) or poor finish. I don't remember if we finished or not. That's the first one that comes to mind, but again knock on wood we and I'm not superstitious. We have very focused group of guys that from a mechanical stand point do a great job of making sure stuff isn't falling off the race cars. It's what we pride ourselves on."
Feedback can be sent to email@example.com Go to our forums to discuss this article |


text:
Shopping Cart
$0.00 (0 items)
Cart Summary
- There was an error
- It was successful
Crocs Duet Sport Kids Realtree Clogs
Post a Review
Crocs Duet Sport Kids Realtree Clogs - One tough pair of slip on clogs, up to anything your kids can put them through.
Crocs Duet Sport Kids Realtree Clogs - The Duet Sport Realtree® clogs from Crocs are lightweight, camo, and soon to be your kids favorite. The soft Croslite™ footbed will keep their feet comfortable and ready to go while out playing in the sun.
- Dual density construction, softer Croslite™ material uppers and footbed
- Durable Croslite™ material outsole
- Realtree™ camo design
- Non-marking Croslite™ outsole
- Easy slip on and off style
Customer Support
We are here to help if you need us, please contact Customer Support at:


text:
The Southern Oregon Foreign Language Articulation Association or SOFLA, is a collaborative organization that brings together foreign language teachers from all levels of instruction in the southern Oregon region. SOFLA was originally established in 1998, and, from 1998-2007, SOFLA organized two to three workshops every year for language teachers in southern Oregon using federal grant money. SOFLA also worked directly with certain school districts to asses their students and provide additional training with funding from the No Child Left Behind program. SOFLA seeks to promote second language proficiency among students by focusing on standards and assessment. Working collaboratively with the Department of Foreign Languages and Literatures at Southern Oregon University, SOFLA developed the SOU Foreign Language High School Proficiency program, in which advanced high school language students receive university credit by demonstrating proficiency in the language (See the "High School Proficiency Program" link for more information).
The SOFLA Team
The SOFLA project team coordinates SOFLA workshops and activities under the direction of project director Dr. Daniel Morris. As we re-instate SOFLA in 2015, we are looking for new members of the project team.
Join us on February 5, 2015 at 4:30 p.m. for a SOFLA organizational meeting in the Meese Room of the Hannon Library on the SOU campus.
If you would like more information about SOFLA, contact Dr. Daniel Morris at firstname.lastname@example.com.


text:
The federal government must release information about how and when it uses cellphone data to track criminal suspects, a U.S. appeals court ruled on Tuesday, saying the public's interest outweighs any privacy concerns, CNN reports.
The American Civil Liberties Union declared victory in the decision, one of several involving technology such as GPS that can be used to track the movements of people using smartphones, laptop computers and other devices.
"The disclosure sought by the plaintiffs would inform this ongoing public policy discussion by shedding light on the scope and effectiveness of cellphone tracking as a law enforcement tool," the three-judge District of Columbia panel said in a 35-page ruling. "It would, for example, provide information about the kinds of crimes the government uses cell phone tracking data to investigate."
"I highly doubt that the 90 percent of Americans who carry cellphones thought that when they got cellphone service they were giving up their privacy in their movements," Catherine Crump, a lawyer for the American Civil Liberties Union who argued the case, was quoted by Reuters as saying.


text:
| |
RATINGS: 28 MEAN: 3.51/5.0 WEIGHTED AVG: 3.37 SEASONAL: Special IBU: 38 EST. CALORIES: 279 ABV: 9.3%
COMMERCIAL DESCRIPTION English: Triple Style Ale aged in Moscatel de Setùbal barrel for 1 year. There are so many barrel aged beers around, but why is it that most of the time barrel aging is reserved for massive, dark beers? We thought that wed give it a try to create a complex barrel aged beer out of something completely different than the usual imperial stout or barley wine. So we took our triple style ale, Xbeeriment Leo, and aged it for a year in a Moscatel de Setùbal barrel. The result is an astonishingly complex beer ..
We Want To Hear From YouJoin us! RateBeer is made by beer enthusiasts for the craft beer community. Your basic membership is free and allows you to read all beer ratings. Click here to create your account... and give your opinion! Join Us » Page 1 2 3 |
about us About RateBeer FAQ Contact/Feedback New Beers |
add Advanced Search Add A Beer Add A Brewer Add A Place Events |
membership Log In Edit Personal Info Buy Premium Membership Your Messages |
the best RateBeer Best 100 Beer Club The Top 50 |


text:
Comment on "Taylor Rule Exchange Rate Forecasting during the Financial Crisis"
In: NBER International Seminar on Macroeconomics 2012
In this note we discuss the paper on exchange rate forecasting by Molodtsova> and Papell (2012). In particular we discuss issues related to forecast origins and forecast> horizons when higher frequency exchange rate movements are predicted using lower> frequency quarterly macroaggregates.
(This abstract was borrowed from another version of this item.)
If you experience problems downloading a file, check if you have the proper application to view it first. In case of further problems read the IDEAS help page. Note that these files are not on the IDEAS site. Please be patient as the files may be large.
This chapter was published in: This item is provided by National Bureau of Economic Research, Inc in its series NBER Chapters with number
12775. | Handle: | RePEc:nbr:nberch:12775 | Contact details of provider: | Postal: | Phone: 617-868-3900 Web page: http://www.nber.org Email: More information through EDIRC |
No references listed on IDEAS
You can help add them by filling out this form.
This item is not listed on Wikipedia, on a reading list or among the top items on IDEAS.
When requesting a correction, please mention this item's handle: RePEc:nbr:nberch:12775. See general information about how to correct material in RePEc.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: ()
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
If references are entirely missing, you can add them using this form.
If the full references list an item that is present in RePEc, but the system did not link to it, you can help with this form.
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your profile, as there may be some citations waiting for confirmation.
Please note that corrections may take a couple of weeks to filter through the various RePEc services.


text:
Grand Theft Auto San Andreas
Gun show t-shirt
Here is a skin modification that will replace the "I Love Los Santos" T Shirt within GTA San Andreas with that of a "Got Your Tickets, to the gun show". This shirt can be found at Binco ingame. This
Show All
Show All
- File Name:
- gunshow.zip
- File Size:
- Date Added:
- 02-20-2009
- Download Last 2 Week:
- 0
- Downloads All Time:
- 70
- Popularity:
- 0.02%


text:
Added fluoride to continue in Tama waterCouncil Chooses Not To Act On Public Hearing IdeaJanuary 10, 2014City water officials last month told the Tama City Council concerns are being voiced in other cities, Des Moines in particular, over the addition of fluoride to municipal water supplies.... DavidGreenIt is not an accident that fluoridation is being challenged around the world in the few countries that carry out the practice. I suggest the council hold the meeting and hear from the experts that oppose fluoridation. The article has an error. It should refer to .4 ppm in the source water and an addition of .3 ppm by the city. 0 Agrees | 0 Disagrees | Report Abuse » MzByrdI appreciate Dr. Kubik's comments. Fluoride in water is well-studied and remains a best-practice for supporting oral health for citizens. "Thank you" to the city council for supporting it! Checkout: iowa.ilikemyteeth**** 0 Agrees | 0 Disagrees | Report Abuse » SSlottIt is not an accident that the United States is 74.6% fluoridated, increased from 73.4% in 2011, in spite of repeated attempts by antifluoridationists to have this valuable public health initiative ceased. Unsubstantiated claims, misrepresentation of science, out-of-context quotes, and presentation of outright misinformation by antifluoridationists have been countered with facts supported by valid scientific evidence, repeatedly, by concerned, knowledgeable healthcare providers and experts, exactly as just occurred in Tama. This has enabled intelligent leaders to make informed decisions on fluoridation, exactly as just occurred in Tama. Steven D. Slott, DDS 0 Agrees | 0 Disagrees | Report Abuse » DavidGreenSteve, You are absolutely correct that fluoridation in the U.S. is not an accident. It is well documented in Christopher Bryson's book The Fluoride Deception, a tremendous insight into the incestuous relationship between fluoride polluting industry and the USPHS in the late 40's and 50's. Here's a stat that puts your percentages in a little perspective. More people drink artificially fluoridated water in the U.S. than in the rest of the world combined. I guess you folks are just smarter than everyone else. Just like the Romans. 0 Agrees | 0 Disagrees | Report Abuse » SSlottDavid Green There is no such thing as "artificially fluoridated water". Fluoride ions occur naturally and are identical regardless the source. Christopher Bryson is an investigative reporter, not a scientist, healthcare expert, or healthcare provider. His book is neither peer-reviewed nor scientific. You are certainly free to cite and obtain your "information" from such dubious "sources", but for those intelligent people who seek honest, accurate information on the public health initiative of water fluoridation, I would advise staying clear of biased "books" and antifluoridationist websites, and instead obtain information from reliable, respected, and primary sources. The websites of the EPA, the CDC, the NSF, the ADA, and the World Health Organization (WHO), each has a wealth of accurate information on water fluoridation readily available to anyone who so desires. Steven D. Slott, DDS 0 Agrees | 0 Disagrees | Report Abuse » DavidGreenNo such thing as artificially fluoridated water??? That would be the water that man puts HFSA into. Since you cite WHO as credible, perhaps you can explain the data from that organization showing no difference in decay rates in 12 year olds regardless of their country's fluoridation of water or salt. You can find that at fluoridealert****; the biased website that you "wouldn't know how to access" but "have visited" but don't monitor. You also cite the CDC. How about explaining their acknowledgement in 1999 that fluoride works primarily topically? One more thing. Why won't you debate Paul Connett from FAN? If he is a wrong as you say, it should be no problem for you to expose that for all the world to see. I went to see Paul last night when he was nearby. He talked a little about the PEW trust and how much money they have behind them. Are they paying you anything to show up and promote fluoridation wherever their is a story? Full disclosure Steve. 0 Agrees | 0 Disagrees | Report Abuse » SSlottDavid Green.......continued In regard to "debating" Connett, of course I won't do so. That would be totally nonsensical. His constant pleadings for debates is his attempt to trivialize a scientific, healthcare issue by throwing out as many unsubstantiated arguments as he can within the short time span allowed for a live "debate", knowing full well that there is no way to adequately address them in such a setting. No, if Connett wants to "debate" this issue then he needs to put his arguments in writing, and have them properly reviewed and addressed by knowledgeable sources. Although Connett purports himself to be some sort of "authority" on fluoridation, the fact is that he has not one, single, peer-reviewed piece of scientific literature on fluoridation, to his name. Steven D. Slott, DDS 0 Agrees | 0 Disagrees | Report Abuse » SSlottDavid Green.....continued From the CDC: "The laboratory and epidemiologic research that has led to the better understanding of how fluoride prevents dental caries indicates that fluoride's predominant effect is posteruptive and topical and that the effect depends on fluoride being in the right amount in the right place at the right time. Fluoride works primarily after teeth have erupted, especially when small amounts are maintained constantly in the mouth, specifically in dental plaque and saliva. Thus, adults also benefit from fluoride, rather than only children, as was previously assumed." To be continued....... Steven D. Slott 0 Agrees | 0 Disagrees | Report Abuse » SSlottDavid Green.......continued As far as the CDC, again, all of the information you seek is readily available from the primary sites. Instead of depending on "fluoridealert****" feed you its "interpretation" of CDC information, why not just go to the CDC website itself and obtain its information unfiltered and unedited? First, "primarily" does not mean "only". Water fluoridation works both systemically and topically. The percentage of each mechanism is irrelevant. The constant exposure of the teeth to low concentrations of fluoride throughout the day is a most effective means of dental decay prevention. Fluoridation provides this. There is no other method of obtaining the amount of dental decay prevention as cost-effectively as water fluoridation. To be continued......... Steven D. Slott, DDS 0 Agrees | 0 Disagrees | Report Abuse » SSlottDavid Green......continued As far as your dependence on snapshots of data to attempt to explain the complex process of dental decay prevention, well, few, if any intelligent people would require an explanation of the fallacy of that "argument". Suffice it to say that it is not possible to accurately assess the efficacy of one factor in decay prevention while controlling for no others. If you care to cite valid, peer-reviewed, scientific studies to support your position, fine. Otherwise you are simply wasting time. The filtered and edited "information" found on "fluoridealert****" and other such biased, antifluoridationist websites has no value, whatsoever. Your dependence on these dubious sources is one main reason that you remain uninformed on this issue. Again, there is a wealth of accurate information readily available from reliable, respected, and primary sources. To be continued....... Steven D. Slott, DDS 0 Agrees | 0 Disagrees | Report Abuse » SSlottDavid Green......continued The only products of the dissociation of HFA are fluoride ions identical to those which already exist in water and which humans have been ingesting since the beginning of time, and barely detectable trace heavy metal contaminants in concentrations so far below EPA mandated maximum safety levels that it is not even a certainty that these contaminants aren't the ones that exist in all water naturally. To be continued...... Steven D. Slott, DDS 0 Agrees | 0 Disagrees | Report Abuse » SSlottDavid Green.......continued There is no such thing as "artificial fluoride" or "artificially fluoridated water". This is simply misinformation you glean from dubious antifluoridationist "sources". Water fluoridation is the process of raising the concentration of fluoride ions in public water systems up to the optimal level for maximum dental decay prevention with no adverse effects. For those water systems which already have an existing level at or above the optimal concentration, no fluoride is needed or added. HFA immediately and completely hydrolyzes (dissociates) at the pH of drinking water. After that point, HFA no longer exists, it does not reach the tap, it is not ingested. Thus, HFA is of no concern, whatsoever. To be continued....... Steven D. Slott, DDS 0 Agrees | 0 Disagrees | Report Abuse » SSlottDavid Green........continued 5. Richard Sauerheber, PhD. Sauerhaber is the "scientific consultant" for "Attorney Deal" in his class-action stirring attempts. A look at Deal's website will show Sauerhaber and his opinions plastered all over it. What fees Sauerhaber may or may not receive for his fluoride "consulting" is anyone's guess. 6. Whatever various family members of Connett, and others who are paid by his antifluoridationist group, for their fluoride chasing activities. 7. FAN operates under the umbrella of another activist organization, so its full expenditures are not readily transparent and available as would be expected of such a non-profit group which asks for donations from the public. So, please, tell us once again who you deem is being "paid" to keep this issue alive. Are you? to be continued....... Steven D. Slott, DDS 0 Agrees | 0 Disagrees | Report Abuse » SSlottDavid Green continued....... 2. The antifluoridationist, William Hirzy. Hirzy is the paid lobbyist for Connett's antifluoridationist group, FAN. Another salary totally dependent on keeping this issue alive. 3. Close Connett affiliate, "Attorney Deal". James Deal has a website devoted entirely to attempts to stir up frivolous class-action lawsuits against fluoridation, from which he would presumably would profit. No fluoridation "controversy", no chance for lucrative attorney fees. 4. Connett affiliate, Alex Jones. Jones most recently began pushing a concoction that purportedly "removes" fluoride from the body. To be continued....... Steven D. Slott, DDS 0 Agrees | 0 Disagrees | Report Abuse » SSlottDavid Green......continued 1. The antifluoridationist/activist, Paul Connett- Paul's "book" on fluoridation, sales of which he pushes at every conceivable opportunity, and from which he receives royalties, sells for $25 per copy. He claims to donate all his royalties to his non-profit Fluoride Action Network, FAN. However, since it seems likely that FAN funds all or part of fluoride-chasing, trips to Australia, New Zealand, Europe, all around the United States, and wherever else he chases it, his "donation" would seem to be little more than a tax strategy. Additionally, both Paul and his wife each receive $1000 per month from their non-profit organization. Thus, we have book royalties, expenses, plus $2k per month for the Connetts To be continued......... Steven D. Slott, DDS 0 Agrees | 0 Disagrees | Report Abuse » SSlottDavid Green Full disclosure? Certainly. Let's begin with the "payment" hypocrisy of you, Paul, and most other antifluoridationists. Neither I, nor any other fluoridation advocate of whom I'm aware, is "paid" or receives any compensation, whatsoever, for our efforts to improve the health of all our citizens through correcting the mounds of misinformation constantly disseminated by uninformed antifluoridationists. Now, contrast this with your antifluoridationist leadership: to be continued......... Steven D. Slott, DDS 0 Agrees | 0 Disagrees | Report Abuse » DavidGreenNo I am not paid, Steve, and I am glad to hear that you aren't either, so we know it is just your professional credibility that is at stake. By the way, Dr Connett arrived by bus to Oshawa Ontario on Thursday. When he speaks his travel expenses are covered by the group who asks him to come and he is quite happy to stay with someone to avoid the expense of a hotel room. Your portrayal of people opposed to fluoridation as being in it for the money is a little comical given all the money spent trying to buy the votes of minority groups by the fluoridation folks in Portland and all the money spent over the years by industry to influence public perception about fluoride risks. I am still looking for the research that backs your suggestion that saliva fluoride levels of 16-18 ppb have any benefit in protecting teeth more than 4-6 ppb. Do you have anything or is that just a speculation? 0 Agrees | 0 Disagrees | Report Abuse » DavidGreenAlso Steve, I am still not clear on whether you consider the data from WHO for 12 year-olds valid. Do you have something that refutes that? Your excuse for not wanting to debate Dr. Connett is not uncommon. It would be equally valid if he said the same thing, yet he hasn't. In fact he has asked for a point by point rebuttal of the arguments made in his book but no one has taken him up on it. Why don't you do that? What exactly are you afraid of? I have been in business for 31 years and one thing we always say is never say anything negative about the competition, because it shows that you are afraid of them. The other fitting line here is: "The person losing an argument is the one doing the most talking". 0 Agrees | 0 Disagrees | Report Abuse » SSlottDavid Green You were the one who brought up the standard, unsubstantiated antifluoridationist allegation of fluoridation advocates being "paid", not I. I simply pointed out your hypocrisy in so doing. I could not care less how much Connett, his family, or any of his affiliates profit by keeping this issue alive. That's entirely up to them and those who choose to pay heed to their nonsense. In regard to your hypocrisy, I have no doubt whatsoever that were any fluoridation advocates being paid that which Connett and his people are being paid,mthat you would ge amongst the first in line to criticize such blatant conflict of interests. Be that as it may, if you don't want Connett's dirty laundry exposed then you need to get past the antifluoridationist obsession with advocates being somehow "paid" and concentrate on properly educating yourself on this issue. Steven D. Slott, DDS 0 Agrees | 0 Disagrees | Report Abuse » SSlottDavid Green As far as your question about the WHO data, the question itself demonstrates your ignorance of scientific study. It is not the data which is in question. It is your attempting to use that data to assess the efficacy of fluoridation, which is the absurdity. With no controls for confounding factors it is ludicrous to attempt to use ANY such snapshot of data to assess one preventive factor. It is of no surprise that you cannot find valid information on fluoride levels in saliva. Antifluoridationist websites do not have such information. Again, if you want accurate, unfiltered, unedited information on fluoridation, stop seeking it from dubious antifluoridationist "sources", and access the information, in its proper context, from the primary sources. Here is where the CDC info may be found, with full references: ***********cdc.gov/mmwr/preview/mmwrhtml/rr5014a1.htm Steven D. Slott, DDS 0 Agrees | 0 Disagrees | Report Abuse » DavidGreenAre you suggesting that my numbers for fluoride levels in saliva in people drinking or not drinking fluoridated water are not accurate? Thank you for confirming that the WHO data is accurate. So what you are suggesting is that the confounding factors all align in one direction in the countries that fluoridate and in the other in countries that don't in order to give the appearance that there is no difference when in fact there is. That doesn't sound too scientific to me. Should we get back to the NIDR study again that gets more or less the same result. .6 of a tooth surface saved out of 128. Then there are the studies that show no change or a lessening of decay in communities that end fluoridation. The study in Comox/Courtenay B.C. is interesting in that the results were never published in Canada and no one would have known about them if they hadn't been published in Denmark. Does that strike you as honest science or political protection of policy? 0 Agrees | 0 Disagrees | Report Abuse » SSlottDavid Green.......continued Even if you subscribe to "0.6 of a tooth surface being saved", untreated decay in but one tooth surface can and does lead to untold amounts of pain, debilitation, loss of multiple, or all of, teeth, systemic illness, life-threatening infection, and even death. Attempts to trivialize untreated dental disease which could be prevented by water fluoridation demonstrate a profound lack of understanding of the overwhelming problem of dental disease in this country and most others. Your conspiracy theories in regard to what you personally consider to be "honest science" are irrelevant. Steven D. Slott, DDS 0 Agrees | 0 Disagrees | Report Abuse » SSlottDavid Green.......continued From the CDC: "Saliva is a major carrier of topical fluoride. The concentration of fluoride in ductal saliva, as it is secreted from salivary glands, is low --- approximately 0.016 parts per million (ppm) in areas where drinking water is fluoridated and 0.006 ppm in nonfluoridated areas. This concentration of fluoride is not likely to affect cariogenic activity. However, drinking fluoridated water, brushing with fluoride toothpaste, or using other fluoride dental products can raise the concentration of fluoride in saliva present in the mouth 100- to 1,000-fold. The concentration returns to previous levels within 1--2 hours but, during this time, saliva serves as an important source of fluoride for concentration in plaque and for tooth remineralization." ***********cdc.gov/mmwr/preview/mmwrhtml/rr5014a1.htm Obviously, what "doesn't sound too scientific" to you, is irrelevant. to be continued..... Steven D. Slott, DDS 0 Agrees | 0 Disagrees | Report Abuse » SSlottDavid Green I'm not "suggesting" anything. I state facts. How you choose to personally attempt to interpret these facts is irrelevant. Once again, the percentage of topical versus systemic effect of water fluoridation is irrelevant in regard to the success of this public health initiative in preventing dental decay. Countless peer-reviewed studies have clearly demonstrated the effectiveness of this initiative. However, as you still seem hung up on saliva concentrations: to be continued........ Steven D. Slott 0 Agrees | 0 Disagrees | Report Abuse » DavidGreenSteve, Thank you for pulling up that statement from the CDC. So an organization that you consider credible, and which has acknowledged that fluorides effect is primarily topical, also acknowledges that the difference in saliva fluoride levels between those drinking fluoridated water and those not, is unlikely to have any effect on decay. I think you have just made my case for me, unless you are suggesting that fluoridated water is having a topical effect as it passes through the mouth on its way to the stomach. 0 Agrees | 0 Disagrees | Report Abuse » Showing 25 of 26 comments Show More Comments
Post a Comment |
News, Blogs & Events Web |